iifl-logo

Marksans Pharma Ltd Historical Data

261.5
(3.54%)
Jun 30, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Marksans Pharma Ltd Historical Data

30/05/2025calendar-icon
30/06/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

02-Jun-2025

260

260254.55255.1516,71418,00,35,918.753,38,153

03-Jun-2025

255.6

262.5254.1261.3521,96431,59,05,800.855,34,328

04-Jun-2025

262

263255.9256.815,42319,37,27,0912,58,362

05-Jun-2025

256.95

261.05256.5257.8513,56716,44,03,380.72,01,241

06-Jun-2025

257.85

261.35251.05251.9523,73029,46,80,701.755,18,468

09-Jun-2025

254.55

257.7252.5253.356,12510,59,54,149.752,12,015

10-Jun-2025

254.9

254.9249.3249.9511,53218,00,41,060.93,49,834

11-Jun-2025

252.15

270.7252263.5551,6671,02,67,01,305.511,44,691

12-Jun-2025

263.55

270.6258259.9531,94146,53,74,433.66,11,909

13-Jun-2025

252

260250.1259.2547,45034,79,34,630.35,51,670

16-Jun-2025

258.05

259.25252257.9545,18421,15,65,2443,43,354

17-Jun-2025

258

258249250.6536,38827,31,04,217.15,91,081

18-Jun-2025

249.95

255.2244.5250.1536,48021,25,10,881.853,20,480

19-Jun-2025

251.5

256242.1247.9561,81432,21,74,260.254,48,674

20-Jun-2025

248.2

249.8236.9524047,80172,78,87,472.0519,34,992

23-Jun-2025

238

243.3235.9240.717,11218,50,50,323.23,23,633

24-Jun-2025

242.7

247.15241.2242.818,83123,21,15,029.054,47,447

25-Jun-2025

243.5

249.9241.824719,55622,81,04,832.854,76,659

26-Jun-2025

248.1

250.95246.1247.0513,16419,14,45,744.454,07,344

27-Jun-2025

248

255.35246.9252.5517,02623,62,32,150.84,46,103

Marksans Pharma: Related NEWS

OrbiMed to Offload 2.27% Stake in Marksans Pharma via Block Deal
11 Jun 2025|12:34 PM

The block deal has been launched at a floor price of ₹249.95 per share, signaling a strategic partial exit by the investor.

Read More
Marksans Pharma’s Relonchem Gets UK MHRA Approval for Baclofen 10 mg
21 Mar 2025|12:02 PM

Relonchem Ltd has secured Marketing Authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for Baclofen 10 mg Tablets

Read More
Marksans Pharma gets USFDA approval for anti-allergy drug
22 Nov 2024|02:54 PM

The US Food and Drug Administration (FDA) approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.